Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT02359227 | Safety Study of Cenderitide in Stable Chronic Heart Failure | PHASE2 | COMPLETED | 14 | — | — | Jan 1, 2015 | Apr 1, 2015 | Feb 10, 2020 | - | — |
| NCT02603614 | Safety Study of Cenderitide in Chronic Stable Heart Failure With Moderate Renal Impairment | PHASE1/PHASE2 | COMPLETED | 8 | — | — | Dec 1, 2015 | Mar 1, 2016 | Feb 10, 2020 | - | — |
| Name | Type | Description |
|---|---|---|
| Cenderitide | DRUG | Cenderitide is a dual receptor natriuretic peptide. |
| Placebo | DRUG | Placebo control |